Piper Sandler Dave Westenberg maintained an Overweight on Akoya Biosciences Inc (NASDAQ: AKYA) and lowered its price target to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE